Literature DB >> 18384982

Cationic lipid-coated magnetic nanoparticles associated with transferrin for gene delivery.

Xiaogang Pan1, Jingjiao Guan, Jung-Woo Yoo, Arthur J Epstein, L James Lee, Robert J Lee.   

Abstract

Cationic lipid-coated magnetic nanoparticles (MPs) associated with transferrin were evaluated as gene transfer vectors in the presence of a static magnetic field. MPs were prepared by chemical precipitation and were surface-coated with cationic lipids, composed of DDAB/soy PC (60:40 mole/mole). These cationic MPs were then combined with polyethylenimine (PEI) condensed plasmid DNA, followed by transferrin. The resulting magnetic electrostatic complexes retained relatively compact particle size and showed complete DNA condensation. Their transfection activity in the presence of a static magnetic field was evaluated by luciferase and green fluorescent protein (GFP) reporter genes. The magnetic complexes exhibited up to 300-fold higher transfection activity compared to commonly used cationic liposomes or cationic polymer complexes, based on luciferase assay. The enhancement in transfection activity was maximized when the cells were exposed to the vectors for a relatively short period of time (15 min), or were treated in media containing 10% serum. Incorporation of transferrin further improved transfection efficiency of the cationic MPs. However, when cells were incubated for 4h in serum-free media, magnetic and non-magnetic vectors showed similar transfection efficiencies. In conclusion, transferrin-associated cationic MPs are excellent gene transfer vectors that can mediate very rapid and efficient gene transfer in vitro in the presence of a magnetic field.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18384982      PMCID: PMC3807797          DOI: 10.1016/j.ijpharm.2008.02.020

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  33 in total

1.  Enhancement of transfection by physical concentration of DNA at the cell surface.

Authors:  D Luo; W M Saltzman
Journal:  Nat Biotechnol       Date:  2000-08       Impact factor: 54.908

2.  Short tandem repeat profiling provides an international reference standard for human cell lines.

Authors:  J R Masters; J A Thomson; B Daly-Burns; Y A Reid; W G Dirks; P Packer; L H Toji; T Ohno; H Tanabe; C F Arlett; L R Kelland; M Harrison; A Virmani; T H Ward; K L Ayres; P G Debenham
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

3.  Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo.

Authors:  F Scherer; M Anton; U Schillinger; J Henke; C Bergemann; A Krüger; B Gänsbacher; C Plank
Journal:  Gene Ther       Date:  2002-01       Impact factor: 5.250

4.  Using magnetic forces to enhance non-viral gene transfer to airway epithelium in vivo.

Authors:  S Xenariou; U Griesenbach; S Ferrari; P Dean; R K Scheule; S H Cheng; D M Geddes; C Plank; E W F W Alton
Journal:  Gene Ther       Date:  2006-06-01       Impact factor: 5.250

5.  Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine.

Authors:  M A Gosselin; W Guo; R J Lee
Journal:  Bioconjug Chem       Date:  2001 Nov-Dec       Impact factor: 4.774

6.  Gene expression in synovial membrane cells after intraarticular delivery of plasmid-linked superparamagnetic iron oxide particles--a preliminary study in sheep.

Authors:  Larry D Galuppo; Sarah W Kamau; Benedikt Steitz; Paul O Hassa; Monika Hilbe; Lloyd Vaughan; Sabine Koch; Alke Fink-Petri; Margarethe Hofman; Heinrich Hofman; Michael O Hottiger; Brigitte von Rechenberg
Journal:  J Nanosci Nanotechnol       Date:  2006 Sep-Oct

7.  Characterization of a novel diolein-based LPDII vector for gene delivery.

Authors:  Wenjin Guo; Michael A Gosselin; Robert J Lee
Journal:  J Control Release       Date:  2002-09-18       Impact factor: 9.776

8.  Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin) conjugated polyethylenimine.

Authors:  Shih-Jiuan Chiu; Naoto T Ueno; Robert J Lee
Journal:  J Control Release       Date:  2004-06-18       Impact factor: 9.776

9.  Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy.

Authors:  Gong Wu; Rolf F Barth; Weilian Yang; Madhumita Chatterjee; Werner Tjarks; Michael J Ciesielski; Robert A Fenstermaker
Journal:  Bioconjug Chem       Date:  2004 Jan-Feb       Impact factor: 4.774

10.  Improved method of recombinant AAV2 delivery for systemic targeted gene therapy.

Authors:  Cathryn Mah; Thomas J Fraites; Irene Zolotukhin; Sihong Song; Terence R Flotte; Jon Dobson; Christopher Batich; Barry J Byrne
Journal:  Mol Ther       Date:  2002-07       Impact factor: 11.454

View more
  18 in total

1.  Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells.

Authors:  Jiang Chang; Archibald Paillard; Catherine Passirani; Marie Morille; Jean-Pierre Benoit; Didier Betbeder; Emmanuel Garcion
Journal:  Pharm Res       Date:  2011-12-14       Impact factor: 4.200

Review 2.  Functional magnetic nanoparticles for non-viral gene delivery and MR imaging.

Authors:  Ruijun Xing; Gang Liu; Jinghan Zhu; Yanglong Hou; Xiaoyuan Chen
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

3.  Solid lipid nanoparticles loaded with anti-microRNA oligonucleotides (AMOs) for suppression of microRNA-21 functions in human lung cancer cells.

Authors:  San-Jun Shi; Zhi-Rong Zhong; Jie Liu; Zhi-Rong Zhang; Xun Sun; Tao Gong
Journal:  Pharm Res       Date:  2011-07-06       Impact factor: 4.200

4.  Enriching Nanoparticles via Acoustofluidics.

Authors:  Zhangming Mao; Peng Li; Mengxi Wu; Hunter Bachman; Nicolas Mesyngier; Xiasheng Guo; Sheng Liu; Francesco Costanzo; Tony Jun Huang
Journal:  ACS Nano       Date:  2017-01-09       Impact factor: 15.881

5.  Click assembly of magnetic nanovectors for gene delivery.

Authors:  Souvik Biswas; Laura E Gordon; Geoffrey J Clark; Michael H Nantz
Journal:  Biomaterials       Date:  2011-01-20       Impact factor: 12.479

Review 6.  Magnetically enhanced nucleic acid delivery. Ten years of magnetofection-progress and prospects.

Authors:  Christian Plank; Olivier Zelphati; Olga Mykhaylyk
Journal:  Adv Drug Deliv Rev       Date:  2011-08-26       Impact factor: 15.470

7.  Nanoparticle formulations that allow for sustained delivery and brain targeting of the neuropeptide oxytocin.

Authors:  Rokon Uz Zaman; Nihal S Mulla; Keegan Braz Gomes; Cherilyn D'Souza; Kevin Sean Murnane; Martin J D'Souza
Journal:  Int J Pharm       Date:  2018-07-19       Impact factor: 5.875

8.  Theranostic agents for intracellular gene delivery with spatiotemporal imaging.

Authors:  Jennifer M Knipe; Jonathan T Peters; Nicholas A Peppas
Journal:  Nano Today       Date:  2013-02-01       Impact factor: 20.722

9.  Nanoparticle encapsulation increases the brain penetrance and duration of action of intranasal oxytocin.

Authors:  Aboagyewaah Oppong-Damoah; Rokon Uz Zaman; Martin J D'Souza; Kevin Sean Murnane
Journal:  Horm Behav       Date:  2018-12-30       Impact factor: 3.587

10.  Acceleration of gene transfection efficiency in neuroblastoma cells through polyethyleneimine/poly(methyl methacrylate) core-shell magnetic nanoparticles.

Authors:  Tewin Tencomnao; Kewalin Klangthong; Nuttaporn Pimpha; Saowaluk Chaleawlert-Umpon; Somsak Saesoo; Noppawan Woramongkolchai; Nattika Saengkrit
Journal:  Int J Nanomedicine       Date:  2012-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.